IDR 179.0
(1.13%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 293.43 Billion IDR | 13.5% |
2022 | 255.25 Billion IDR | 31.94% |
2021 | 193.46 Billion IDR | 46.03% |
2020 | 132.48 Billion IDR | 2.48% |
2019 | 129.28 Billion IDR | -6.02% |
2018 | 137.56 Billion IDR | 11.36% |
2017 | 123.53 Billion IDR | -1.56% |
2016 | 125.48 Billion IDR | -1.53% |
2015 | 127.43 Billion IDR | -2.98% |
2014 | 131.35 Billion IDR | 11.08% |
2013 | 118.25 Billion IDR | 10.75% |
2012 | 106.77 Billion IDR | 12.89% |
2011 | 94.58 Billion IDR | 12.45% |
2010 | 84.11 Billion IDR | 8.66% |
2009 | 77.41 Billion IDR | 7.21% |
2008 | 72.2 Billion IDR | 40.29% |
2007 | 51.47 Billion IDR | 42.18% |
2006 | 36.2 Billion IDR | 75.64% |
2005 | 20.61 Billion IDR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 104.7 Billion IDR | 27.5% |
2024 Q3 | 125.76 Billion IDR | 20.11% |
2024 Q1 | 82.12 Billion IDR | -11.2% |
2023 Q4 | 92.48 Billion IDR | 28.92% |
2023 Q2 | 71.58 Billion IDR | 10.54% |
2023 Q3 | 71.74 Billion IDR | 0.22% |
2023 Q1 | 64.75 Billion IDR | 77.34% |
2023 FY | 289.71 Billion IDR | 13.5% |
2022 Q2 | 51.67 Billion IDR | -10.14% |
2022 Q4 | 36.51 Billion IDR | -66.67% |
2022 FY | 255.25 Billion IDR | 31.94% |
2022 Q1 | 57.5 Billion IDR | 36.69% |
2022 Q3 | 109.56 Billion IDR | 112.05% |
2021 Q4 | 42.06 Billion IDR | -38.23% |
2021 Q2 | 40.97 Billion IDR | -3.22% |
2021 Q1 | 42.33 Billion IDR | 87.93% |
2021 Q3 | 68.09 Billion IDR | 66.2% |
2021 FY | 193.46 Billion IDR | 46.03% |
2020 Q2 | 26.78 Billion IDR | -37.93% |
2020 FY | 132.48 Billion IDR | 2.48% |
2020 Q4 | 22.52 Billion IDR | -43.73% |
2020 Q3 | 40.03 Billion IDR | 49.49% |
2020 Q1 | 43.14 Billion IDR | 43.72% |
2019 Q1 | 35.26 Billion IDR | 14.81% |
2019 FY | 129.28 Billion IDR | -6.02% |
2019 Q4 | 30.02 Billion IDR | -7.86% |
2019 Q3 | 32.58 Billion IDR | 3.71% |
2019 Q2 | 31.41 Billion IDR | -10.9% |
2018 FY | 137.56 Billion IDR | 11.36% |
2018 Q4 | 30.71 Billion IDR | -10.76% |
2018 Q3 | 34.41 Billion IDR | -1.55% |
2018 Q2 | 34.95 Billion IDR | -6.73% |
2018 Q1 | 37.48 Billion IDR | 29.68% |
2017 Q2 | 31.91 Billion IDR | 4.1% |
2017 Q1 | 30.66 Billion IDR | 0.05% |
2017 Q3 | 32.04 Billion IDR | 0.4% |
2017 FY | 123.53 Billion IDR | -1.56% |
2017 Q4 | 28.9 Billion IDR | -9.81% |
2016 Q3 | 26.33 Billion IDR | -29.37% |
2016 Q4 | 30.64 Billion IDR | 16.39% |
2016 FY | 125.48 Billion IDR | -1.53% |
2016 Q2 | 37.28 Billion IDR | 19.4% |
2016 Q1 | 31.22 Billion IDR | 1.41% |
2015 Q4 | 30.79 Billion IDR | 9.71% |
2015 FY | 127.43 Billion IDR | -2.98% |
2015 Q2 | 34.86 Billion IDR | 3.43% |
2015 Q1 | 33.71 Billion IDR | -1.38% |
2015 Q3 | 28.06 Billion IDR | -19.5% |
2014 FY | 131.35 Billion IDR | 11.08% |
2014 Q1 | 32.64 Billion IDR | 13.11% |
2014 Q2 | 32.28 Billion IDR | -1.11% |
2014 Q4 | 34.18 Billion IDR | 6.0% |
2014 Q3 | 32.24 Billion IDR | -0.11% |
2013 Q4 | 28.86 Billion IDR | -18.5% |
2013 Q2 | 27.66 Billion IDR | 5.15% |
2013 Q1 | 26.31 Billion IDR | -5.23% |
2013 FY | 118.25 Billion IDR | 10.75% |
2013 Q3 | 35.41 Billion IDR | 28.01% |
2012 Q1 | 27.34 Billion IDR | 7.61% |
2012 FY | 106.77 Billion IDR | 12.89% |
2012 Q3 | 25.67 Billion IDR | -1.24% |
2012 Q4 | 27.76 Billion IDR | 8.13% |
2012 Q2 | 25.99 Billion IDR | -4.91% |
2011 Q2 | 22.34 Billion IDR | 7.24% |
2011 Q4 | 25.4 Billion IDR | -2.26% |
2011 Q1 | 20.83 Billion IDR | 0.0% |
2011 Q3 | 25.99 Billion IDR | 16.33% |
2011 FY | 94.58 Billion IDR | 12.45% |
2010 FY | 84.11 Billion IDR | 8.66% |
2009 FY | 77.41 Billion IDR | 7.21% |
2008 FY | 72.2 Billion IDR | 40.29% |
2007 FY | 51.47 Billion IDR | 42.18% |
2006 FY | 36.2 Billion IDR | 75.64% |
2005 FY | 20.61 Billion IDR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 762.07 Billion IDR | 61.495% |
PT Merck Tbk | 200.74 Billion IDR | -46.175% |
PT Phapros, Tbk | 428.44 Billion IDR | 31.512% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 827.82 Billion IDR | 64.553% |
PT Tempo Scan Pacific Tbk | 3255.8 Billion IDR | 90.987% |